Genetic Technologies Ltd (NASDAQ:GENE)
| 2.85 Data as of May 17 |  +0.17 / +6.34%Today’s Change | 2.00 Today|||52-Week Range 6.20 | +30.73% Year-to-Date |
Latest GENE News | Press Releases
No recent news for Genetic Technologies Ltd.
Today’s Trading
| Previous close | 2.68 |
| Today’s open | 2.67 |
| Day’s range | 2.60 - 2.98 |
| Volume | 161,470 |
| Average volume (3 months) | 93,619 |
| Market cap | $45.2M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -643.18% |
| Earnings growth (this year) | -35.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -16.58% |
| P/E ratio | NM |
| Price/Sales | 14.60 |
| Price/Book | 3.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AFFYAffymax Inc | -0.10 | -6.99% |
| CLSNCelsion Corp | +0.07 | +7.44% |
| DRIOLabStyle Innovations... | +0.10 | +3.45% |
| ROSGRosetta Genomics Ltd | -0.15 | -4.23% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $3.8M |
| Annual profit (last year) | -$5.5M |
| Net profit margin | -143.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer Alison Jane Mew |
Chief Financial Officer & Secretary Thomas G. Howitt, CPA |
Corporate headquarters Fitzroy, Victoria (vic) |
Forecasts
